Paul Hockings, Senior MR Imaging Director at Antaros Medical, will be presenting next week at the 8th Annual MASH Drug Development Summit.
His talk ‘From Steatosis to Fibrosis and Beyond – What non-invasive Imaging Can Do in MASLD/MASH)’ will cover:
- Understanding the complexity of MASLD/MASH including downstream consequences
- New advances in clinical non-invasive imaging of fibrosis and cirrhosis
- How insights from multiple biomarkers can shape decision making in drug development
Join us for Paul’s presentation at the MASH Drug Development Summit on Wednesday 25 September @ 16:00 EDT. The MASH Drug Development Summit takes place from 24-26 September in Boston, MA.
And to learn more about liver disease and cirrhosis, be sure to register for our upcoming webinar: Cracking Cirrhosis: Complexity of Chronic Liver Disease and Insights for Drug Development